Olympic Protein Technologies

Olympic Protein Technologies

opt.bio
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Olympic Protein Technologies is a private, revenue-generating contract research organization providing end-to-end protein science services to biotechnology and pharmaceutical clients. The company's core competency lies in overcoming challenges in protein expression and purification, supported by a leadership team with deep industrial experience from companies like Amgen and Exelixis. Operating from a lab in Seattle, OPT offers a personalized, full-service model from construct design through biophysical characterization, positioning itself as a specialized partner for reagent and therapeutic candidate development. While not developing its own therapeutics, its services are critical enablers for clients' pipelines across multiple therapeutic areas.

ProteomicsAntibodies

Technology Platform

Integrated workflow for recombinant protein production featuring DNA sequence optimization, multi-system expression (E. coli, insect, mammalian cells), protein purification & modification, and characterization via biophysical analysis (e.g., SPR).

Opportunities

Growing demand for complex biologics and novel modalities (bispecifics, ADCs, cell therapies) creates a need for specialized protein production expertise that large CROs may lack.
The trend toward outsourcing in biopharma R&D provides a favorable market for niche, high-touch service providers with proven technical capabilities.

Risk Factors

Revenue is susceptible to biotech funding cycles and client concentration.
The company faces competition from both large global CROs and other niche players.
Its reputation depends entirely on successfully executing technically challenging projects for clients.

Competitive Landscape

OPT competes in the fragmented protein services CRO market. It differentiates through deep industrial experience, a personalized service model, and a focus on solving challenging expression/purification problems. Key competitors range from large players like Charles River Laboratories, Lonza, and Thermo Fisher to smaller specialty labs like Absolute Antibody, ProteoGenix, and numerous academic core facilities.